Cytori Therapeutics (NASDAQ: CYTX) will provide a live webcast of its fourth quarter and year end financial results and business update on Tuesday, March 11, 2014 at 5:00 PM Eastern Time.
The dial-in information is as follows:
Dial-In Number: +1.877.402.3914Conference ID: 8527517
Prior to the webcast, at approximately 4:05 PM Eastern Time on March 11, Cytori will issue its year-end earnings release which will review Cytori's fourth quarter and full year performance. The webcast will be available both live and by replay two hours after the call in the “
” section of the Company's Investor Relations website.
Cytori Therapeutics is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and other medical conditions. Our scientific data suggest ADRCs improve blood flow. As a result, we believe these cells can be applied across multiple “ischemic” conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori’s proprietary technologies and products, including the Celution® System product family.